Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaxem Hib vs Hiberix booster in Chinese infants
NCT01226953Phase 3Completed
- Sponsor
- Novartis
- Start
- Oct 2010
- Primary completion
- Dec 2010
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of VaxemHIB in Haemophilus influenzae type b infection (Hib), sponsored by Novartis. Started Oct 2010; status: completed.
02
Drugs
VaxemHIB
03
Conditions
Haemophilus influenzae type b infection (Hib)
Beyond the preview
Go deeper on NCT01226953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01226953.